BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33753215)

  • 1. Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review.
    Vinarov Z; Abdallah M; Agundez JAG; Allegaert K; Basit AW; Braeckmans M; Ceulemans J; Corsetti M; Griffin BT; Grimm M; Keszthelyi D; Koziolek M; Madla CM; Matthys C; McCoubrey LE; Mitra A; Reppas C; Stappaerts J; Steenackers N; Trevaskis NL; Vanuytsel T; Vertzoni M; Weitschies W; Wilson C; Augustijns P
    Eur J Pharm Sci; 2021 Jul; 162():105812. PubMed ID: 33753215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of advanced methods and models to study drug absorption and related processes: An UNGAP perspective.
    Wilson CG; Aarons L; Augustijns P; Brouwers J; Darwich AS; De Waal T; Garbacz G; Hansmann S; Hoc D; Ivanova A; Koziolek M; Reppas C; Schick P; Vertzoni M; García-Horsman JA
    Eur J Pharm Sci; 2022 May; 172():106100. PubMed ID: 34936937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network.
    Vinarov Z; Abrahamsson B; Artursson P; Batchelor H; Berben P; Bernkop-Schnürch A; Butler J; Ceulemans J; Davies N; Dupont D; Flaten GE; Fotaki N; Griffin BT; Jannin V; Keemink J; Kesisoglou F; Koziolek M; Kuentz M; Mackie A; Meléndez-Martínez AJ; McAllister M; Müllertz A; O'Driscoll CM; Parrott N; Paszkowska J; Pavek P; Porter CJH; Reppas C; Stillhart C; Sugano K; Toader E; Valentová K; Vertzoni M; De Wildt SN; Wilson CG; Augustijns P
    Adv Drug Deliv Rev; 2021 Apr; 171():289-331. PubMed ID: 33610694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.
    Abuhelwa AY; Foster DJR; Upton RN
    AAPS J; 2016 Sep; 18(5):1309-1321. PubMed ID: 27495120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review.
    Vertzoni M; Augustijns P; Grimm M; Koziolek M; Lemmens G; Parrott N; Pentafragka C; Reppas C; Rubbens J; Van Den Αbeele J; Vanuytsel T; Weitschies W; Wilson CG
    Eur J Pharm Sci; 2019 Jun; 134():153-175. PubMed ID: 30991092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically Based Oral Absorption Modelling to Study Gut-Level Drug Interactions.
    Chung J; Kesisoglou F
    J Pharm Sci; 2018 Jan; 107(1):18-23. PubMed ID: 28847476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group.
    Koziolek M; Alcaro S; Augustijns P; Basit AW; Grimm M; Hens B; Hoad CL; Jedamzik P; Madla CM; Maliepaard M; Marciani L; Maruca A; Parrott N; Pávek P; Porter CJH; Reppas C; van Riet-Nales D; Rubbens J; Statelova M; Trevaskis NL; Valentová K; Vertzoni M; Čepo DV; Corsetti M
    Eur J Pharm Sci; 2019 Jun; 134():31-59. PubMed ID: 30974173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interindividual and intraindividual variability of fasted state gastric fluid volume and gastric emptying of water.
    Grimm M; Koziolek M; Kühn JP; Weitschies W
    Eur J Pharm Biopharm; 2018 Jun; 127():309-317. PubMed ID: 29522898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of gastrointestinal physiology on drug absorption in special populations--An UNGAP review.
    Stillhart C; Vučićević K; Augustijns P; Basit AW; Batchelor H; Flanagan TR; Gesquiere I; Greupink R; Keszthelyi D; Koskinen M; Madla CM; Matthys C; Miljuš G; Mooij MG; Parrott N; Ungell AL; de Wildt SN; Orlu M; Klein S; Müllertz A
    Eur J Pharm Sci; 2020 Apr; 147():105280. PubMed ID: 32109493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.
    Parsons RL
    Clin Pharmacokinet; 1977; 2(1):45-60. PubMed ID: 322910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food, gastrointestinal pH, and models of oral drug absorption.
    Abuhelwa AY; Williams DB; Upton RN; Foster DJ
    Eur J Pharm Biopharm; 2017 Mar; 112():234-248. PubMed ID: 27914234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of GI conditions critical to oral drug absorption in malnourished children.
    Freerks L; Papadatou Soulou E; Batchelor H; Klein S
    Eur J Pharm Biopharm; 2019 Apr; 137():9-22. PubMed ID: 30735799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.
    Sjögren E; Abrahamsson B; Augustijns P; Becker D; Bolger MB; Brewster M; Brouwers J; Flanagan T; Harwood M; Heinen C; Holm R; Juretschke HP; Kubbinga M; Lindahl A; Lukacova V; Münster U; Neuhoff S; Nguyen MA; Peer Av; Reppas C; Hodjegan AR; Tannergren C; Weitschies W; Wilson C; Zane P; Lennernäs H; Langguth P
    Eur J Pharm Sci; 2014 Jun; 57():99-151. PubMed ID: 24637348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative Analysis of Gastrointestinal Physiology for Better Prediction of Oral Drug Absorption and Interaction].
    Shirasaka Y
    Yakugaku Zasshi; 2020; 140(5):599-608. PubMed ID: 32378658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine gastrointestinal physiology: Breeds variations that can influence drug absorption.
    Oswald H; Sharkey M; Pade D; Martinez MN
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):192-203. PubMed ID: 26409436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dynamic gastric environment and its impact on drug and formulation behaviour.
    Van Den Abeele J; Rubbens J; Brouwers J; Augustijns P
    Eur J Pharm Sci; 2017 Jan; 96():207-231. PubMed ID: 27597144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.
    Jones HM; Parrott N; Ohlenbusch G; Lavé T
    Clin Pharmacokinet; 2006; 45(12):1213-26. PubMed ID: 17112297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Impact of Physiological Properties of the Gastrointestinal Tract On Drug In Vivo Performance Using Physiologically Based Biopharmaceutics Modeling and Virtual Clinical Trials.
    Jereb R; Opara J; Bajc A; Petek B
    J Pharm Sci; 2021 Aug; 110(8):3069-3081. PubMed ID: 33878322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.